Profiles of Genomic Instability in High-Grade Serous Ovarian Cancer Predict Treatment Outcome

Zhigang C. Wang, Nicolai J. Birkbak, Aedín C. Culhane, Ronny Drapkin, Aquila Fatima, Ruiyang Tian, Matthew Schwede, Kathryn Alsop, Kathryn E. Daniels, Huiying Piao, Joyce F. Liu, Dariush Etemadmoghadam, Alexander Miron, Helga B. Salvesen, Gillian Mitchell, Anna DeFazio, John Quackenbush, Ross S. Berkowitz, J. Dirk Iglehart, David D.l. Bowtell, Ursula A. MatulonisClinical 2012 · DOI

Abstract

Separating HGSC by LOH-based clustering produces remarkably stable subgroups in three different cohorts. Patients in the various LOH clusters differed with respect to chemotherapy resistance, and the extent of LOH correlated with PFS. LOH burden may indicate vulnerability to treatment targeting DNA repair, such as PARP1 inhibitors.
BibTeX
@inproceedings{wang2012profiles,
  author = {Zhigang C. Wang and Nicolai J. Birkbak and Aedín C. Culhane and Ronny Drapkin and Aquila Fatima and Ruiyang Tian and Matthew Schwede and Kathryn Alsop and Kathryn E. Daniels and Huiying Piao and Joyce F. Liu and Dariush Etemadmoghadam and Alexander Miron and Helga B. Salvesen and Gillian Mitchell and Anna DeFazio and John Quackenbush and Ross S. Berkowitz and J. Dirk Iglehart and David D.L. Bowtell and Ursula A. Matulonis and Ursula A. Matulonis},
  title = {{Profiles of Genomic Instability in High-Grade Serous Ovarian Cancer Predict Treatment Outcome}},
  booktitle = {Clinical},
  year = {2012},
  doi = {10.1158/1078-0432.ccr-12-0857},
}

Loading related content...

Figure